Core Viewpoint - Alphabet (GOOGL) is transitioning from a laggard to a leader in the tech sector, showing improved performance and strong catalysts for growth in the second half of the year [3][4]. Financial Performance - GOOGL's stock price is currently $206.09, up 42% from its 52-week low, with a P/E ratio of 21.95 and a price target of $211.53 [2]. - The stock has gained over 18% in the past quarter, outperforming many peers and the overall market [2][3]. - Despite being up only 5.5% year-to-date, recent performance acceleration indicates potential for further growth [3]. Strategic Developments - Alphabet has entered a groundbreaking agreement with Kairos Power and the Tennessee Valley Authority to supply 50 megawatts of nuclear power to its data centers, with plans to expand to 500 megawatts by 2035 [4][5]. - This initiative positions Alphabet as a leader in sustainable energy solutions for its AI workloads, addressing significant power demands [5][6]. Cloud Services Growth - A significant six-year cloud services deal valued at $10 billion has been established between Meta Platforms and Alphabet, enhancing Alphabet's cloud infrastructure for AI workloads [7][8]. - This partnership underscores the increasing demand for Alphabet's cloud services and reinforces its strategic role in the AI ecosystem [8][9]. Technical Analysis - The stock is showing bullish technical signals, having broken into a new upward channel after a period of sideways movement [10][11]. - A sustained price above $200 could lead to further gains, especially if positive news continues [11][12].

NEW YORK, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in RxSight, Inc. ("RxSight, Inc." or the "Company") (NASDAQ: RXST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of RxSight, Inc. investors who were adversely affected by alleged securities fraud between November 7, 2024 and July 8, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/rxsight-inc-lawsuit- ...

NEW YORK, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Fiserv, Inc. ("Fiserv, Inc." or the "Company") (NYSE: FI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fiserv, Inc. investors who were adversely affected by alleged securities fraud between July 24, 2024 and July 22, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/fiserv-inc-lawsuit-submission ...

NEW YORK, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Capricor investors who were adversely affected by alleged securities fraud between October 9, 2024 and July 10, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/capricor-therape ...

NEW YORK, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ("Replimune Group, Inc." or the "Company") (NASDAQ: REPL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Replimune Group, Inc. investors who were adversely affected by alleged securities fraud between November 22, 2024 and July 21, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/ps ...

NEW YORK, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Centene Corporation ("Centene" or the "Company") (NYSE: CNC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Centene investors who were adversely affected by alleged securities fraud between December 12, 2024 and June 30, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/centene-corporation-lawsuit ...

NEW YORK, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. ("Unicycive Therapeutics, Inc." or the "Company") (NASDAQ: UNCY) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Unicycive Therapeutics, Inc. investors who were adversely affected by alleged securities fraud between March 29, 2024 and June 27, 2025. Follow the link below to get more information and be contacted by a member of our team: ...

Core Viewpoint - A class action securities lawsuit has been filed against Altimmune, Inc. due to alleged securities fraud affecting investors between August 10, 2023, and June 25, 2025 [1] Group 1: Lawsuit Details - The lawsuit follows a press release from Altimmune on June 26, 2025, announcing disappointing results from the IMPACT Phase 2b MASH trial of Pemvidutide, where the company failed to achieve statistical significance in the primary endpoint of fibrosis reduction [2] - The stock price of Altimmune plummeted by 53.2%, from $7.71 per share on June 25, 2025, to $3.61 per share on June 26, 2025, following the announcement of the trial results [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until October 6, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States, with over 70 employees dedicated to serving clients [4]

Core Viewpoint - A class action securities lawsuit has been filed against Tesla, Inc. alleging securities fraud related to the company's autonomous driving technology and its implications for safety and regulatory scrutiny [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover losses for Tesla investors affected by alleged securities fraud between April 19, 2023, and June 22, 2025 [1]. - The complaint claims that Tesla overstated the effectiveness of its autonomous driving technology, leading to risks of dangerous operation and potential violations of traffic laws [2]. - It is alleged that these misrepresentations increased the likelihood of heightened regulatory scrutiny, thereby overstating Tesla's business and financial prospects [2]. Group 2: Participation Information - Investors who suffered losses during the relevant timeframe have until October 3, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [2]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating no financial obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - Hims & Hers Health, Inc. is facing a class action securities lawsuit due to alleged securities fraud that occurred between April 29, 2025, and June 23, 2025 [1][2] Group 1: Allegations and Impact - The lawsuit claims that Hims was involved in the deceptive promotion and sale of illegitimate versions of Wegovy®, which jeopardized patient safety [2] - It is alleged that this situation posed a significant risk of termination of the Company's collaboration with Novo Nordisk [2] - The defendants' positive statements regarding the Company's business and prospects are claimed to be materially misleading and lacking a reasonable basis [2] Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until August 25, 2025, to request to be appointed as lead plaintiff [3] - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4]